Clinical and immunologic effects of Staphylococcal protein A immunoadsorption therapy for inhibitor to factor VIII
- 30 April 1992
- journal article
- Published by Elsevier in Transfusion Science
- Vol. 13 (2) , 223-232
- https://doi.org/10.1016/0955-3886(92)90175-g
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Elective surgery in a haemophilic patient with high titre inhibitors: use of extracorporeal protein A immunoabsorption.Journal of Clinical Pathology, 1990
- Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1American Journal of Hematology, 1989
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- FACTOR VIII INHIBITOR IN MILD HAEMOPHILIABritish Journal of Haematology, 1986
- The use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with aids and aids-related conditionsJournal of Clinical Apheresis, 1986
- Factor VIII antibody in a patient with mild haemophiliaBritish Journal of Haematology, 1985
- Interaction of Polyclonal Human IgE with Protein‐A from Staphylococcus aureusImmunological Reviews, 1978
- Binding of IgA to Protein‐A‐Containing Staphylococci: Relationship to SubclassesScandinavian Journal of Immunology, 1976
- The Mode of Action of Antibodies which Destroy Factor VIIIBritish Journal of Haematology, 1972
- Quantitative immunology of immune hemolytic anemiaJournal of Clinical Investigation, 1971